High Flow Oxygen
High Flow Oxygen is a pharmaceutical drug with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Postoperative High-flow Nasal Oxygenation After High-risk Surgery in the Frail Adult
Pain Biomarker Study
Building Respiratory Support in East Africa Through High Flow Versus Standard Flow Oxygen Evaluation
Improving Outcomes of Respiratory Patients With Exertional Hypoxemia
High Flow Oxygen Therapy and Acute Ischemic Stroke
Clinical Trials (7)
Postoperative High-flow Nasal Oxygenation After High-risk Surgery in the Frail Adult
Pain Biomarker Study
Building Respiratory Support in East Africa Through High Flow Versus Standard Flow Oxygen Evaluation
Improving Outcomes of Respiratory Patients With Exertional Hypoxemia
High Flow Oxygen Therapy and Acute Ischemic Stroke
High Flow Oxygen With THRIVE Gives Better Oxygenation in Rapid Sequence Induction Patients
Investigating the Effects of Hyperoxia on Fractional Flow Reserve
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7